{
    "title": "Mylan beats profit on COVID-19 stockpiling, maintains forecast",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8307615/Mylan-sticks-forecast-quarter-benefits-COVID-19-stockpiling.html",
    "date": "2020-05-11",
    "keywords": [
        "drug",
        "revenue",
        "company",
        "year",
        "share",
        "cold",
        "drugmaker",
        "half",
        "profit",
        "spread",
        "coronavirus",
        "trading",
        "track",
        "merger",
        "pfizer",
        "offpatent",
        "unit",
        "upjohn",
        "delayed",
        "deal",
        "wixela",
        "infection",
        "traction",
        "emergency",
        "allergy",
        "treatment",
        "face",
        "pressure",
        "mylan",
        "production",
        "malaria",
        "hydroxychloroquine",
        "president",
        "trump",
        "game",
        "changer",
        "fight",
        "respiratory",
        "illness",
        "virus",
        "supply",
        "chain",
        "availability",
        "implementation",
        "restructuring",
        "program",
        "loss",
        "refinitiv",
        "quarter",
        "demand",
        "coldeeze",
        "perforomist",
        "covid19",
        "outbreak",
        "range",
        "resumption",
        "hospital",
        "reporting",
        "sibi",
        "joseph",
        "trisha",
        "roy",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}